A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
Clinical trial NCT07340190 · RECRUITING
Trial details
- NCT number
- NCT07340190
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-12
- Primary completion
- 2028-03-09
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.